{"id":892845,"title":"Extragenital testing increases detection of gonorrhea and chlamydia: Impact of implementing nucleic acid amplification testing, CCDR 46(9) - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T03:53:43.943000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/nucleic-acid-amplification-testing-gonorrhea-chlamydia.html","snippet":"NAAT testing for gonorrhea and chlamydia Download this article as a PDF Published by: The Public Health Agency of Canada Issue: Volume 46–9: Force Health Protection Date published: September 3, 2020 ISSN: 1481-8531 Subscribe to CCDR Submit your manuscript Information for authors…","rawSnapshotUrl":"/api/snapshots/raw/892845","browseUrl":"https://replay.healtharchive.ca/job-7/20260306035343/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-9-september-3-2020/nucleic-acid-amplification-testing-gonorrhea-chlamydia.html#ha_snapshot=892845","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}